Elanco Animal Health Inc
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. RESULTS OF OPERATIONS
Results of Operations
The following discussion and analysis of our results of operations should be read along with our condensed consolidated financial statements and the notes thereto. Our results of operations for the periods presented below may not be comparable with prior periods or with our results of operations in the future due to many factors, including but not limited to the factors identified above.
| Three Months Ended March 31, | |||
|---|---|---|---|
| (Dollars in millions) | 2026 | 2025 | % Change |
| Revenue | $1,371 | $1,193 | 15% |
| Cost of sales | 586 | 509 | 15% |
| Gross profit | 785 | 684 | 15% |
| Research and development | 97 | 94 | 3% |
| Marketing, selling and administrative | 381 | 341 | 12% |
| Amortization of intangible assets | 138 | 128 | 8% |
| Asset impairment, restructuring and other special charges | 16 | 9 | 78% |
| Interest expense, net of capitalized interest | 57 | 40 | 43% |
| Other expense, net | 9 | 12 | (25)% |
| Income before income taxes | 87 | 60 | 45% |
| Income tax expense (benefit) | 30 | (7) | NM |
| Net income | $57 | $67 | (15)% |
Certain amounts and percentages may reflect rounding adjustments.
NM - Not meaningful
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.